Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
Tech workforce program championed by former Chiefs star graduates its first KC class
An education initiative recently launched in Kansas City not only focuses on lifting up young people from low-income backgrounds and helping them succeed in the high-tech sector, said pro football hall of famer Will Shields: it upends a cycle of decline and replaces it with building blocks. i.c.stars, headquartered in Chicago, launched in Kansas City…
Build-A-Bear founder joins VFA’s board, lauding group as an ‘onramp’ to entrepreneurship for overlooked young professionals
ST. LOUIS — A hometown founder and entrepreneurial icon is joining the board of one of the region’s premiere work placement opportunities for early-career professionals. Maxine Clark, founder of Build-A-Bear Workshop — the teddy-bear-themed retailer she launched in 1997 in St. Lous — is the latest appointment to the national board of directors for Venture…
Leveraging KC’s resources: How the right people at the right time can unlock a startup’s potential
The level of collaboration seen in Kansas City’s entrepreneurial ecosystem is unmatched by peer communities, said Jill Meyer, noting it’s not a phenomenon that developed by accident. And it takes transparency and trust, she added. “There is a lot of work that resource partners do to make sure that our companies and our founders have…
Looking for investors? A startup’s first ask shouldn’t be for money, leading VCs say
Most startup founders think of funding as transactional, Darcy Howe shared, but it’s actually relational. “You’ve got to have relationships with people long before they’ll fund and that includes angels and all the others,” the KCRise Fund founding managing director told a crowd gathered at UMKC’s Bloch Executive Hall for Startland News’ Kansas City Startups…